] i to purinergic neurotransmitter ATP was also found to be smaller in cells from obstructed bladders (p<0.05), although trans-membrane influx by high K depolarization was not significantly affected.
Introduction
Human fetal bladder outflow obstruction (BOO) is an exclusively male disease, usually caused by posterior urethral valves (PUV). This condition affects 1/5000 male births and is the commonest cause of end-stage renal failure in children. 1 In addition to renal impairment, two-thirds of boys with PUV also suffer significant bladder dysfunction, 2 with common urodynamic findings of bladder instability, low capacity and poor bladder emptying. 3 Our current understanding on the consequences of fetal bladder outflow obstruction in humans derives from postnatal studies of urinary tract function in boys with posterior urethral valves. In infancy these bladders generally have small capacity and thick walls, 4 correlating with detrusor muscle overactivity on urodynamics. 3 Later the bladder develops large capacity and becomes hypocontractile, often with progression to complete detrusor failure. 3 Less is known about the effects of bladder outflow obstruction on human fetal urinary tract structure and function. In several studies of human fetuses with bladder outflow obstruction some histological changes have been documented.
Freedman et al described thickened bladder walls with increased smooth muscle and collagen, but no change to their relative content. 5 Kim et al reported increased muscle thickness but with decreased collagen relative to muscle. 6 Workman and Kogan also found increased muscle thickness in human fetal bladders with posterior urethral valves, although in contrast to previous findings, there was a disproportionate increase in connective tissue. 7 However, few studies have examined the pathophysiology of the fetal detrusor muscle exposed to bladder outflow obstruction.
The need to understand functional abnormalities as a consequence of PUV necessitates the use of experimental animal models to study the normally developing and obstructed fetal bladders. For these purposes, the ovine fetus has proved to be a useful model, as it is convenient for experimental intra-uterine surgical manipulation, and successful induction of bladder outflow obstruction produces dysregulation of normal growth and development. 8 In two recent studies, severe obstruction of the fetal sheep bladder, by urachal and urethral obstruction, resulted in a large hypocontractile organ, accompanied by functional denervation and contractile abnormalities 9,10 and bladder remodelling from enhanced apoptosis in detrusor muscle. 11 An altered collagen content in the detrusor wall has been shown to be a significant contributor to contractile abnormalities. However whether other cell components, smooth muscle in particular, are also involved, cannot be resolved in the multicellular preparations used in the study. 10 A crucial question yet to be answered is whether intracellular Ca 2+ regulation, a determinant of smooth muscle contraction, is altered due to obstruction. Of particular interest is whether alterations to cholinergic and purinergic pathways in detrusor muscle occur, such 4 as observed in both adult animal models of BOO and human neurogenic bladders [12] [13] [14] [15] when purinergic mechanisms assume a greater importance. We therefore tested the hypothesis that changes to intracellular Ca 2+ regulation contribute to impaired contractility of smooth muscle from obstructed fetal bladders. We used single smooth muscle cells isolated from the obstructed sheep fetal bladder. The intensity ratios at 340 nm and 380 nm excitation (R, 340/380) were calibrated using an in vitro method and converted into Ca 2+ concentration according to the following equation: Aliquots of 10 mM aqueous stocks of carbachol, ATP and ABMA (,  methylene-ATP) were added to Tyrode's to achieve the desired concentrations. Powder forms of caffeine and KCl were added to Tyrode's solution to make 20 mM caffeine and high-K (120 mM) solutions; no osmotic corrections were made.
Data analysis and statistical methods:
Results are expressed as means ± SE, n is the number of preparations unless otherwise indicated. Student's t-test was used to test the difference between two means. The null hypothesis was rejected for p<0.05.
EC 50 values (concentrations producing 50% of maximal effect) were obtained by the least-squares fit to the data points with the Hill equation:
Where y is the proportional response, y max the maximum effect, x the concentration of an agonist, k the EC 50 value, n the Hill coefficient. KaleidaGraph and Clampfit programs were used for curve fitting and kinetic analysis. ] i could be elicited by 10
-100 µM carbachol in these fetal detrusor myocytes. Figure 2B ).
This observation suggests that in addition to attenuated efficacy, the sensitivity of muscarinic receptors to their neutrotransmitter was also compromised. The shape of the two curves was similar, however, with a Hill coefficient near to unity in both groups (1.45±0.22 and 1.13±0.16 for control and obstruction respectively; p=0.32). Evidence for impaired Ca 2+ extrusion/re-uptake was also sought by measurement of maximal rate of relaxation following Ca 2+ release by carbachol. A slower rate is apparent in Figure 4A following Figure 3 ). Thus an attenuation of ATP transient is unlikely to be mediated by an effect on Ca 2+ influx via Ca 2+ channels.
Discussion
The present study has demonstrated that while steady-state cytosolic Ca 2+ levels remain unaltered, the major receptor functions coupled to a rise of intracellular Ca 2+ are down-regulated in fetal detrusor smooth muscle following severe BOO. These changes appear to be specific as Ca 2+ entry by high K-induced depolarization was not significantly affected. These cellular lesions are likely to affect the contractile response to neutrotrasmitters and thus bladder function in utero. Both muscarinic and purinergic receptors were implicated. Of particular importance is the muscarinic system, as it is the predominant mechanism to provide Ca 2+ for contractile proteins in bladder, evidenced by the large magnitude of carbachol-induced Ca 2+ transients compared with other pathways (Figure 3) . The compromised receptor function manifests as decreased receptor efficacy, indicated by the attenuated response to maximal dose of the agonist. Consistent with reduced receptor sensitivity to the ligand, the potency of the agonist was also decreased.
To date, no study has examined changes to intracellular Ca 2+ regulation in fetal detrusor myocytes due to BOO. However, reduced receptor responses to neurotransmitters have been documented in hypertrophic muscle in adult hollow organs following obstruction or increased afterload. Impaired muscarinic as well as purinergic responses have been observed in hypertrophied human bladders and in adult models of severe bladder hypertrophy [12] [13] [14] [15] . A reduction in -adrenergic receptor responsiveness and subsequent altered myocardial contractile function has also been observed with pressure overload-induced cardiac hypertrophy. 16 This implies that compromised receptor function may be part of the pathogenesis of muscular hypertrophy. Interestingly hypertrophic changes to smooth muscle cells have been observed from the present model of BOO, 11 suggesting that changes to receptor function are part of hypertrophic remodeling of fetal detrusor muscle following obstruction. The underlying mechanisms for altered receptor function are not fully understood at present but are likely to be multi-factorial. A primary cause for the impaired receptor function may be due to reduced receptor density, as has been observed with muscarinic receptors in detrusor muscle. 17 However, a reduction of the total number of receptors cannot explain attenuated agonist potency, which further indicates reduced receptor sensitivity. The latter can at least in part be attributable to decreased receptor affinity to its transmitter. Indeed, lower receptor affinity has been observed in hypertrophic detrusor muscle, consistent with a shift in the ratio of M2/M3 subtypes . 16 A switch from subtype M3 to M2 would have an effect on the receptor affinity and hence the sensitivity to cholinergic neurotransmitters. Apart from alterations to receptors per se, abnormalities "downstream" from the receptors may also be responsible, which has been suggested for impaired 11 responsiveness to adrenergic stimulation. 13 As such, impaired downstream coupling to the SR Ca 2+ release (see later) has been shown in the present study, which would additionally contribute to the reduced efficacy and sensitivity of muscarinic receptors.
Altered Ca 2+ responses to neutrotransmitters may be compared with contractile abnormalities in obstructed fetal bladders. In the same model of in utero BOO, reduced contractile responses to nervemediated stimulation, as well as to agonists, have been observed. 9, 10 Denervation and a reduced muscle response to neurotransmitters/agonists were both implicated, but it was not possible to determine if the latter observation was due to a cellular defect or to a greater deposition of extracellular matrix in the form of collagen and elastin. The present study suggests that compromised receptor function in smooth muscle is at least a partial contributor to reduced contractility. Both the reduced maximal Ca 2+ rise and potency may explain the reduced contractile response to cholinergic and purinergic agonists such as carbachol and ABMA (,  methylene-ATP). In addition, a slower Ca 2+ removal following contractile activation (see later discussion) would render myofilaments exposed to prolonged above-threshold levels of Ca 2+ and compromise their ability to generate phasic contractions. This could be another contributing factor to reduced contractility in BOO. The change in EC 50 of carbachol-induced Ca 2+ transients was in contrast to the previous study, which did not show a change to EC 50 to carbachol, when tension was recorded. 10 However, the highest carbachol concentration in the previous study was 10 µM, and may not have produced a maximal response, in particular in obstructed bladders. An earlier work by Levin et al 18 found no significant differences between contractile responses to ATP, carbachol and KCl in fetal sheep bladders following a shorterterm obstruction. Together with our observation this suggests that these changes to excitatory stimuli only occur following longer-term obstruction, which represent cellular lesions in the de-compensated phase of BOO.
At the cellular level, the reduced receptor efficacy and sensitivity to muscarinic stimulation in BOO preparations may be associated with cellular signaling/coupling dysfunction. 
